Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant


Journal

Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 22 7 2021
medline: 25 3 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

Fosfomycin trometamol (FT) has shown promising

Identifiants

pubmed: 34286658
doi: 10.1080/1120009X.2021.1955203
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fosfomycin 2N81MY12TE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-102

Auteurs

Meltem Polat (M)

Department of Pediatric Infectious Diseases, Erzurum Research and Training Hospital, Erzurum, Turkey.
Faculty of Medicine, Department of Pediatric Infectious Diseases, Pamukkale University, Denizli, Turkey.

Aslınur Ozkaya-Parlakay (A)

Department of Pediatric Infectious Diseases, Yildirim Beyazit University Ankara City Hospital, Ankara, Turkey.

Anıl Tapısız (A)

Department of Pediatric Infectious, School of Medicine, Diseases Gazi University, Ankara, Turkey.

Soner Sertan Kara (SS)

Department of Pediatric Infectious Diseases, Erzurum Research and Training Hospital, Erzurum, Turkey.

Selçuk Yüksel (S)

Faculty of Medicine, Department of Pediatric Nephrology, Pamukkale University, Denizli, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH